Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family

[1]  T. Hortobágyi,et al.  Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. , 2016, Brain : a journal of neurology.

[2]  C. van Broeckhoven,et al.  Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort , 2015, Brain : a journal of neurology.

[3]  C. van Broeckhoven,et al.  Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort , 2015, Neurology.

[4]  H. Braak,et al.  PART is part of Alzheimer disease , 2015, Acta Neuropathologica.

[5]  Thomas Wisniewski,et al.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy , 2015, Acta Neuropathologica.

[6]  Thomas Arzberger,et al.  Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies , 2015, Journal of Neural Transmission.

[7]  L. Naccache,et al.  Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin. , 2014, JAMA neurology.

[8]  B. Leavitt,et al.  Progranulin in neurodegenerative disease , 2014, Trends in Neurosciences.

[9]  J. Schneider,et al.  A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases. , 2014, Journal of neuropathology and experimental neurology.

[10]  F. Lamari,et al.  Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration , 2014, neurogenetics.

[11]  B. Avants,et al.  White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  C. van Broeckhoven,et al.  Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. , 2013, JAMA neurology.

[13]  M. Bozzali,et al.  Structural brain signature of FTLD driven by Granulin mutation. , 2012, Journal of Alzheimer's disease : JAD.

[14]  D. Mari,et al.  GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype. , 2013, Journal of Alzheimer's disease : JAD.

[15]  C. Duyckaerts,et al.  Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation. , 2013, Journal of Alzheimer's disease : JAD.

[16]  C. van Broeckhoven,et al.  Mechanisms of Granulin Deficiency: Lessons from Cellular and Animal Models , 2012, Molecular Neurobiology.

[17]  I. Mackenzie,et al.  Advances in understanding the molecular basis of frontotemporal dementia , 2012, Nature Reviews Neurology.

[18]  V. Hachinski.  Staging and Natural History of Cerebrovascular Pathology in Dementia , 2012, Neurology.

[19]  Marc Cruts,et al.  Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.

[20]  V. Deramecourt,et al.  Staging and natural history of cerebrovascular pathology in dementia , 2012, Neurology.

[21]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[22]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[23]  C. Jack,et al.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.

[24]  D. Leys,et al.  Cerebrovascular Lesions in Patients with Frontotemporal Lobar Degeneration: A Neuropathological Study , 2012, Neurodegenerative Diseases.

[25]  S. Pereson,et al.  A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.

[26]  J. Whitwell,et al.  Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology , 2012, Nature Reviews Neurology.

[27]  J. Rohrer,et al.  Phenotypic signatures of genetic frontotemporal dementia. , 2011, Current opinion in neurology.

[28]  D. Galimberti,et al.  Heterosexual Pedophilia in a Frontotemporal Dementia Patient with a Mutation in the Progranulin Gene , 2011, Biological Psychiatry.

[29]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[30]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[31]  Olaf Ansorge,et al.  FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. , 2011, Brain : a journal of neurology.

[32]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[33]  J. Gunter,et al.  Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN , 2011, Neurology.

[34]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[35]  N. Cairns,et al.  Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43 , 2011, Journal of Molecular Neuroscience.

[36]  William T. Hu,et al.  Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. , 2011, Archives of neurology.

[37]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[38]  N. Bresolin,et al.  Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. , 2011, Journal of Alzheimer's disease : JAD.

[39]  S. Cappa,et al.  From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. , 2011, Journal of Alzheimer's disease : JAD.

[40]  N. Bresolin,et al.  Cerebrospinal fluid biomarkers in Progranulin mutations carriers. , 2011, Journal of Alzheimer's disease : JAD.

[41]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[42]  Sébastien Ourselin,et al.  Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations☆ , 2010, NeuroImage.

[43]  E. Warrington,et al.  Progranulin-associated primary progressive aphasia: A distinct phenotype? , 2010, Neuropsychologia.

[44]  N. Bresolin,et al.  Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease , 2009, Journal of the Neurological Sciences.

[45]  H. Kretzschmar,et al.  A new subtype of frontotemporal lobar degeneration with FUS pathology. , 2009, Brain : a journal of neurology.

[46]  S. Mead,et al.  Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  C R Jack,et al.  Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations , 2009, Neurology.

[48]  S. Engelborghs,et al.  Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His , 2009, Neurology.

[49]  K. Sleegers,et al.  Serum biomarker for progranulin‐associated frontotemporal lobar degeneration , 2009, Annals of neurology.

[50]  C. Jack,et al.  Prominent phenotypic variability associated with mutations in Progranulin , 2009, Neurobiology of Aging.

[51]  C. Broeckhoven,et al.  Granulin mutations associated with frontotemporal lobar degeneration and related disorders: An update , 2008, Human mutation.

[52]  G. Binetti,et al.  Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration , 2008, Neurology.

[53]  C. Broeckhoven,et al.  Progranulin variability has no major role in Parkinson disease genetic etiology , 2008, Neurology.

[54]  Peter Heutink,et al.  Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia , 2008, The Lancet Neurology.

[55]  K. Sleegers,et al.  Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease , 2008, Neurology.

[56]  C. Broeckhoven,et al.  Progranulin genetic variability contributes to amyotrophic lateral sclerosis , 2008, Neurology.

[57]  Marc Cruts,et al.  Loss of progranulin function in frontotemporal lobar degeneration. , 2008, Trends in genetics : TIG.

[58]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[59]  Eric Guedj,et al.  Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. , 2008, Brain : a journal of neurology.

[60]  Andrew King,et al.  A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. , 2008, Brain : a journal of neurology.

[61]  Julie S Snowden,et al.  Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. , 2008, Brain : a journal of neurology.

[62]  C. Broeckhoven,et al.  Progranulin locus deletion in frontotemporal dementia , 2008, Human mutation.

[63]  D. Geschwind,et al.  Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative , 2007, The Lancet Neurology.

[64]  B. Dubois,et al.  Progranulin null mutations in both sporadic and familial frontotemporal dementia , 2007, Human mutation.

[65]  J. Trojanowski,et al.  Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. , 2007, Archives of neurology.

[66]  K. Sleegers,et al.  Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia , 2007, Human mutation.

[67]  P. Pietrini,et al.  Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation , 2007, Neurology.

[68]  Clifford R Jack,et al.  Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. , 2007, Archives of neurology.

[69]  R. Petersen,et al.  Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations , 2007, Journal of neuropathology and experimental neurology.

[70]  J. Hardy,et al.  Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis–frontotemporal dementia phenotypes , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[71]  C. van Broeckhoven,et al.  Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. , 2006, Current Alzheimer research.

[72]  D. Neary,et al.  Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. , 2006, Brain : a journal of neurology.

[73]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[74]  P. Pietrini,et al.  Characteristics of frontotemporal dementia patients with a Progranulin mutation , 2006, Annals of neurology.

[75]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[76]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[77]  C. Jack,et al.  Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. , 2006, Brain : a journal of neurology.

[78]  Holger Hummerich,et al.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.

[79]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[80]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[81]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[82]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[83]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[84]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[86]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[87]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[88]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.